BioBridge at the 4th Cuban Biotechnology Forum: Building New Biopharmaceutical Bridges Between China, Cuba, and Latin America
At BioBridge, we are pleased to announce that on November 4, from 1:00 p.m. to 6:00 p.m., we will host our panel session at the Kempinski Hotel in Shanghai as part of the 4th Cuban Biotechnology Forum. This event will strengthen the strategic partnership between China, Cuba, and Latin America in the biopharmaceutical sector. Our session will focus on regulatory affairs, project incubation, financing, and access to international markets.
Our panel will build on the growing momentum of biopharmaceutical cooperation between Cuba and China, aiming to consolidate Hebei BioBridge Medical Technology Co., Ltd. as a two-way bridge connecting the biopharmaceutical industries of China, Cuba, and Latin America.
This panel follows our inauguration in Shijiazhuang as the first wholly Cuban-owned company from Cuba's biopharmaceutical sector to establish a presence in China. We are based in the High-Tech Industrial Development Zone of Hebei Province, home to several leading Chinese pharmaceutical companies.
This milestone marked a decisive step toward strengthening bilateral cooperation. BioBridge was established with the mission of serving as a two-way bridge connecting the biopharmaceutical industries of China, Cuba, and Latin America, helping them broaden their development opportunities, expand their reach, and strengthen the presence of their products in international markets.
During our panel at the 4th Cuban Biotechnology Forum, participants will address key areas including regulatory harmonization, project incubation, the identification of scientific collaboration opportunities, the engagement of specialized professionals, and financing management. At BioBridge, we emphasize that these comprehensive services facilitate project alignment with current regulations in Cuba, China, and Latin America, streamline approval processes, and support the successful implementation of joint initiatives.
Our panel will also highlight our project incubation services, designed to promote joint initiatives by identifying opportunities for scientific collaboration, engaging qualified professionals, and facilitating access to financing. We expect these activities to connect universities, research centers, startups, and small businesses with strategic partners across the three markets.
We believe our distinctive strength lies in our unique business model, through which we provide clients with customized solutions and a diverse portfolio of products and projects focused on areas of high demand and strong innovation potential. Our presence in China is particularly important for the Cuban biopharmaceutical industry, as it facilitates and accelerates the entry of Cuban products into the vast and promising Chinese market. We also act as representatives, advisors, and intermediaries, offering comprehensive services that help Cuban companies establish and expand their operations.
At BioBridge, our mission is to facilitate cross-border collaboration, unlock market access, and foster sustainable growth. Equally important is our commitment to strengthening relationships with other organizations in the sector, particularly universities, research institutions, startups, and small enterprises.
Within the framework of the 4th Cuban Biotechnology Forum, our panel will serve as a platform for presenting project portfolios, identifying investment opportunities, exchanging regulatory experiences, and promoting technological partnerships. We also aim to strengthen the presence of Cuban and Latin American biopharmaceutical products in the Chinese market while creating opportunities for Chinese companies to access markets across the region.
Through this event, we reaffirm our commitment to South-South cooperation and a shared innovation model that contributes to expanding access to medicines and healthcare technologies. Our panel on November 4 at the Kempinski Hotel in Shanghai will provide another valuable opportunity to build bridges between science, industry, and the markets of China, Cuba, and Latin America.